Reimbursement prices for medical devices in Japan are determined by the Chuikyo committee under MHLW. Pricing considers clinical effectiveness, cost-effectiveness, safety, & comparison with existing devices. Manufacturers submit data for evaluation. Prices are either set based on market equivalents or through cost-calculation methods, ensuring alignment with Japan’s healthcare system & economic sustainability.